Article Navigation

Back To Main Page


 

More Articles

Mesothelioma: More About this Asbestos Cancer


by: David Arnold Livingston

Cancers and other forms of diseases are usually named
according to the part of the body or the internal organ
where abnormal growth of malignant cells takes place.
In the case of Mesothelioma, the abnormal cells grow in
the mesothelium, a surface cell layer that covers and
protects most internal organs. Normally, the
mesothelium produces small amount of fluid in order to
lubricate its layers—one of which directly covers the
organ—and allow the movement of the organs, like the
expansion and contraction of the lungs. A Mesothelioma
cancer patient’s mesothelium produces too much of this
lubricating fluid, thereby damaging nearby tissues and
organs. The most common form of Mesothelioma is Pleural
Mesothelioma, which begins in the Pleural or
Peritoneum, the membrane that lines the chest cavity
and covers the lungs.

About 2,000 cases of Mesothelioma have been noted
yearly in United States. This is still a rare disease
to consider, although the reported incidents have
escalated in the past two decades. It has been observed
and proven that heavy and long exposure to asbestos is
the prime cause of Mesothelioma. Asbestos is a group of
minerals in strong, flexible and fibrous form. It is
used in industrial products such as cement, brake
linings, textiles, electrical insulation, flooring
products, chemical filters, fireproofing materials and
others. This explains why most Mesothelioma patients
are working in construction sites, shipyards and
manufacturing companies of said industrial products.
Small asbestos particles float in the air and are
either inhaled or swallowed by workers or persons
within the vicinity. Aside from Mesothelioma, these
people can acquire asbestosis, a non-cancerous chronic
lung sickness and other forms of cancer of the lungs,
cancer of the larynx and kidney.

Asbestos-related Mesothelioma comprise only 70 to 80
percent of the all the reported cases of the said
cancer. There are reported Mesothelioma cases wherein
the patients did not have any known exposure to
asbestos. Some have been exposed only for a short
period of time but still developed the cancer 20 to 50
years after the exposure, like in the case of a
Mesothelioma cancer patient who only washed clothes
that have been exposed to asbestos. Likewise, asbestos
fibers that have been stuck in the hair strands of a
factory worker can also risk the health of others whom
he lives with. It is therefore important for workers
exposed to asbestos to change their clothes and take a
shower before leaving the workplace to prevent his
family members or companions from inhaling the asbestos
particles and thus, from acquiring Mesothelioma.

The Mesothelioma cancer is slow-forming. That’s why one
develops the cancer so many years after the exposure to
asbestos. Some develop the cancer fifty years after the
exposure, which makes it hard to determine whether the
person has Mesothelioma or not, especially when the
patient has no knowledge of the exposure to asbestos.
Moreover, malignant Mesothelioma shows signs similar to
those of other ailments such as pneumonia. Symptoms of
Pleural Mesothelioma also evident in other illnesses
include: shortness of breath, persistence of cough,
weight loss and chest pain. Peritoneal Mesothelioma,
which affects the abdominal cavity, is indicated by
swelling of and pain in the abdomen, weight loss, bowel
obstruction, anemia, blood clotting abnormalities and
fever.

Complete physical examination is needed to make sure
one has Mesothelioma cancer. This includes xrays of the
body part where the symptoms are felt or seen, CT scan
and MRI. To confirm Mesothelioma, a biopsy is also
performed by a surgeon or oncologist (a physician who
is specializing in the diagnosis and treatment of a
cancer). The sample tissue removed by the surgeon is
examined by the pathologist. Once confirmed, the doctor
then finds out the extent of the cancer, which is
crucial to the treatment of Mesothelioma. Although
malignant, Mesothelioma when earlier diagnosed can
still be treated. Most Mesothelioma patients undergo
surgery, radiation therapy and chemotherapy.




Latest Cancer News:



FDA panel votes against Xgeva for prostate cancer


A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often


NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors


As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds?


We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger


India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation


The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds


TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer


Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News


News Image
Daily Mail

News Image
Breast cancer kills older women more often
Fox News
Print Email Share Comments Recommend Tweet Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed ...
Breast cancer kills older women more often: studyReuters
Older women at breast cancer death riskTimes of India
Breast cancer screening 'no longer justified' and causes 7000 women a year to ...Daily Mail
ABC News -Tempo
all 100 news articles »
Insight: Komen charity under microscope for funding, science - Reuters


News Image
Los Angeles Times

News Image
Insight: Komen charity under microscope for funding, science
Reuters
By Sharon Begley and Janet Roberts | NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it ...
Komen Board's Wisdom Lost on Scott WalkerHuffington Post (blog)
Komen foundation shouldn't give any money to Planned ParenthoodBaltimore Sun
Komen executive quits as questions persistLos Angeles Times

all 3,873 news articles »
FDA panel votes against Xgeva for prostate cancer - The Associated Press


News Image
USA TODAY

News Image
FDA panel votes against Xgeva for prostate cancer
The Associated Press
WASHINGTON (AP) ? A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients The Food and ...
Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer DrugBloomberg
FDA questions Amgen drug for prostate cancerUSA TODAY
FDA Panel Votes Against Expanding Use Of Amgen Drug XgevaFox Business

all 87 news articles »
Pa. woman gets probation for fake cancer claims - USA TODAY



News Image
Pa. woman gets probation for fake cancer claims
USA TODAY
(AP) ? A Pennsylvania woman who submitted nearly $100000 worth of fake cancer treatment insurance claims for herself and her husband must repay the money while she serves nearly nine years on probation. The Observer-Reporter of Washington, ...

and more »
program takes cancer patients on Road to Recovery - Chicago Daily Herald



News Image
program takes cancer patients on Road to Recovery
Chicago Daily Herald
By Elisabeth Mistretta Kathy Miller of Arlington Heights sat inside Northwest Community Hospital near her home two years ago, feeling beaten down from radiation and chemotherapy treatments to treat her stage-four throat cancer.
Winter adds to ordeal of cancer patientsSTLtoday.com

all 2 news articles »
Slow-Growing Prostate Cancer Is Still 'Real Cancer' - Medscape



News Image
Slow-Growing Prostate Cancer Is Still 'Real Cancer'
Medscape
February 8, 2012 ? Low-grade low-volume prostate cancer often grows very slowly, and men presenting with this diagnosis might never experience morbidity or mortality as a result of the condition. However, hearing the emotionally charged term "cancer" ...
Ask Dr. K: Hot flashes in men are caused by low testosteroneGreenville Daily Reflector

all 3 news articles »
DNA sequencing helps identify cancer cells for immune system attack - Washington University in St. Louis News


News Image
Washington University in St. Louis News

News Image
DNA sequencing helps identify cancer cells for immune system attack
Washington University in St. Louis News
By Michael C. Purdy DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research, in mice, appears online Feb. 8 in Nature.

and more »
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center - Sacramento Bee



News Image
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center
Sacramento Bee
Montblanc and Texas Children's Cancer Center have joined together to support excellence in patient care, research and education to enhance the health and well being of our nation's children. To show personal commitment to this cause, Montblanc has ...
Texas Children's partners with Montblanc to raise fundsHouston Business Journal

all 8 news articles »
Breast cancer claims Purdue astronaut Janice Voss, 55 - Journal and Courier


News Image
RedOrbit

News Image
Breast cancer claims Purdue astronaut Janice Voss, 55
Journal and Courier
Astronaut Janice E. Voss, a Purdue University graduate and one of the few women launched into space, died Monday in Scottsdale, Ariz., after a battle with breast cancer. She was 55. Voss was part of five space shuttle missions, spending a total of 49 ...
Cancer Claims Five-Time Shuttle AstronautDiscovery News
Janice Voss, Shuttle Astronaut, Dies of Cancer at 55ThirdAge
NASA Astronaut Janice Voss Loses Battle Against Breast CancerRedOrbit
WIFR -French Tribune -Boston.com
all 190 news articles »
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review - Fox Business


News Image
Insciences Organisation

News Image
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review
Fox Business
VX) experimental breast cancer drug pertuzumab, opening the way for a launch as early as 2012 for a product the Swiss company hopes can contain damage from lost sales when top seller Herceptin loses patent protection in a few years' time.
Roche breast cancer drug gets FDA priority reviewMarketWatch
FDA rewards Roche with priority review for blockbuster cancer drugFierceBiotech
FDA will speed up review of Roche cancer drugCBS News
PMLiVE -HemOncToday
all 53 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org